Search Results - Elisabetta Falvo

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Engineered Human Nanoferritin Bearing the Drug Genz-644282 for Cancer Therapy by Elisabetta Falvo, Alessandro Arcovito, Giamaica Conti, Giuseppe Cipolla, Martina Pitea, Veronica Morea, Verena Damiani, Gianluca Sala, Giulio Fracasso, Pierpaolo Ceci

    Published in Pharmaceutics (2020-10-01)
    Get full text
    Article


  2. 2

    Targeting MDM2 affects spastin protein levels and functions: implications for HSP treatment by Francesca Sardina, Federica Polverino, Sonia Valentini, Claudia Carsetti, Elisabetta Falvo, Giada Tisci, Silvia Soddu, Fabiola Moretti, Alessandro Paiardini, Cinzia Rinaldo

    Published in Cell Death Discovery (2025-02-01)
    Get full text
    Article


  3. 3

    Mitoxantrone-Loaded Nanoferritin Slows Tumor Growth and Improves the Overall Survival Rate in a Subcutaneous Pancreatic Cancer Mouse Model by Giamaica Conti, Martina Pitea, Riccardo Ossanna, Roberta Opri, Giada Tisci, Elisabetta Falvo, Giulio Innamorati, Esther Ghanem, Andrea Sbarbati, Pierpaolo Ceci, Giulio Fracasso

    Published in Biomedicines (2021-11-01)
    Get full text
    Article


  4. 4

    Nose-to-brain selective drug delivery to glioma via ferritin-based nanovectors reduces tumor growth and improves survival rate by Francesco Marrocco, Elisabetta Falvo, Luciana Mosca, Giada Tisci, Alessandro Arcovito, Alice Reccagni, Cristina Limatola, Roberta Bernardini, Pierpaolo Ceci, Giuseppina D’Alessandro, Gianni Colotti

    Published in Cell Death and Disease (2024-04-01)
    Get full text
    Article


  5. 5

    Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas. by Claudio Pulito, Irene Terrenato, Anna Di Benedetto, Etleva Korita, Frauke Goeman, Andrea Sacconi, Francesca Biagioni, Giovanni Blandino, Sabrina Strano, Paola Muti, Marcella Mottolese, Elisabetta Falvo

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


  6. 6

    Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers by Giulio Fracasso, Elisabetta Falvo, Giada Tisci, Gianluca Sala, Gianni Colotti, Sara Cingarlini, Claudia Tito, Sandra Bibbo, Cristina Frusteri, Elisa Tremante, Elena Giordani, Patrizio Giacomini, Pierpaolo Ceci

    Published in Heliyon (2023-10-01)
    Get full text
    Article


  7. 7

    Targeted allele-specific FGFR2 knockdown via human recombinant ferritin nanoparticles for personalized treatment of Crouzon syndrome by Federica Tiberio, Martina Salvati, Luca Polito, Giada Tisci, Alessia Vita, Ornella Parolini, Luca Massimi, Lorena Di Pietro, Pierpaolo Ceci, Gianpiero Tamburrini, Alessandro Arcovito, Elisabetta Falvo, Wanda Lattanzi

    Published in Molecular Therapy: Nucleic Acids (2025-03-01)
    Get full text
    Article


Search Tools: